Literature DB >> 11807320

Myelomeningocele in a child with intrauterine exposure to efavirenz.

Carlo Fundarò, Orazio Genovese, Claudia Rendeli, Enrica Tamburrini, Elio Salvaggio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11807320     DOI： 10.1097/00002030-200201250-00025

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  34 in total

1.  Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

Authors:  Susan B Brogly; Mark J Abzug; D Heather Watts; Coleen K Cunningham; Paige L Williams; James Oleske; Daniel Conway; Rhoda S Sperling; Hans Spiegel; Russell B Van Dyke
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

2.  Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.

Authors:  Molly L Nozyce; Yanling Huo; Paige L Williams; Suad Kapetanovic; Rohan Hazra; Sharon Nichols; Scott Hunter; Renee Smith; George R Seage; Patricia A Sirois
Journal:  Pediatr Infect Dis J       Date:  2014-11       Impact factor: 2.129

3.  Implications of gender and pregnancy for antiretroviral drug dosing.

Authors:  Brookie M Best; Edmund V Capparelli
Journal:  Curr Opin HIV AIDS       Date:  2008-05       Impact factor: 4.283

4.  Efavirenz pharmacokinetics during pregnancy and infant washout.

Authors:  Regis Kreitchmann; Stein Schalkwijk; Brookie Best; Jiajia Wang; Angela Colbers; Alice Stek; David Shapiro; Tim Cressey; Mark Mirochnick; David Burger
Journal:  Antivir Ther       Date:  2019

5.  Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals.

Authors:  Katherine M Knapp; Susan B Brogly; Daniel G Muenz; Hans M L Spiegel; Daniel H Conway; Gwendolyn B Scott; Jeffrey T Talbot; David E Shapiro; Jennifer S Read
Journal:  Pediatr Infect Dis J       Date:  2012-02       Impact factor: 2.129

6.  First trimester exposure to antiretroviral therapy and risk of birth defects.

Authors:  Kelesitse Phiri; Sonia Hernandez-Diaz; Kate B Dugan; Paige L Williams; Judith A Dudley; Astride Jules; S Todd Callahan; George R Seage; William O Cooper
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

Review 7.  Treatment of HIV infection in pregnant women: antiretroviral management options.

Authors:  Mona R Loutfy; Sharon L Walmsley
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  Neurological and psychiatric adverse effects of antiretroviral drugs.

Authors:  Michael S Abers; Wayne X Shandera; Joseph S Kass
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

Review 9.  Efavirenz--still first-line king?

Authors:  Brookie M Best; Miguel Goicoechea
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-07       Impact factor: 4.481

10.  Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.

Authors:  Patricia A Sirois; Yanling Huo; Paige L Williams; Kathleen Malee; Patricia A Garvie; Betsy Kammerer; Kenneth Rich; Russell B Van Dyke; Molly L Nozyce
Journal:  Pediatr Infect Dis J       Date:  2013-06       Impact factor: 2.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.